Medtronic plc announced that the Medtronic Micra Transcatheter Pacing System (TPS) was successfully implanted in nearly all patients in the trial and met its safety and effectiveness endpoints with wide margins. These data, from the Medtronic Micra TPS Global Clinical Trial, were presented during a late-breaking special report session at the 2015 American Heart Association Scientific Sessions and simultaneously published in the New England Journal of Medicine.
